Aracytin is used to treat cancer and some types of leukemia, such as acute myeloid leukemia. It works by stopping the growth of cancer cells by affecting their genetic material, preventing their division and spread. This medication is given intravenously or intrathecally, depending on the treatment plan. It is administered under close medical supervision to ensure its effectiveness and monitor its side effects, which may include low blood cells, nausea, vomiting, and mouth ulcers. Continuous monitoring is required throughout the treatment period to ensure response and reduce complications. Therefore,
Aracytin is considered one of the essential medications used in chemotherapy protocols to control some types of blood cancer.